CCMR program is operated under the leadership of an advisory board and an organization committee. The advisory board is co-chaired by Professor Dayi Hu and Professor Linong Ji and is composed of leaders and experts of Chinese College of Cardiovascular Physicians (CCCP) and Chinese Endocrinologists Associations (CEA), leaders from Ministry of Health, academic researchers of evidence based medicine, and leaders from VitalStrategic Research Institute (VSRI). The organization committee is chaired by the Chief Medical Officer of VSRI, Dr. Danyi Zhang and is composed of key functional members of VSRI and representatives from CCCP and CEA.
For each individual study within the CCMR program, there is a separate steering committee and an organization committee. The steering committee is primarily composed of clinical experts in a particular disease area who are not necessary be the members of CCCP or CEA.
The diagram below illustrates the organizational strucutre of the CCMR program:
Advisory Board
The advisory board is primarily responsible for setting the strategic direction and objectives of the entire program and for ensuring the integrity and the quality of the execution. See more about the advisory board .
